Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Driehaus Small/Mid Cap Growth Fund. This analysis is provided for institutional research purposes only and is not investment advice.
"The Driehaus Small/Mid Cap Growth Strategy capped 2025 with strong Q4 outperformance, positioning aggressively in secular industrials and biotech as small-cap earnings enter an expected multi-year acceleration cycle."
Driehaus Capital Management reports a strong fourth quarter of 2025 for its Small/Mid Cap Growth Strategy, outperforming its Russell 2500 Growth Index benchmark by 142 basis points with a 1.75% net return. For the full year 2025, the strategy returned 9.98% net, trailing the benchmark slightly by 33 basis points. The firm highlights a supportive economic backdrop characterized by monetary easing, strong productivity growth (+4.9% in Q3), and a massive wave of AI capex and data center spending. While active small-cap managers endured a historic, challenging underperformance stretch post-April, small-cap earnings (NTM EPS) have sharply rebounded from their 2023-2024 recession and are expected to outpace large-cap growth. Structurally, the portfolio shifted dynamically by cutting technology software exposure over software demand concerns, while building a significant overweight in healthcare (biotech and diagnostics) and maintaining its largest allocation in secular industrials (aerospace, nuclear, and grid infrastructure). Management maintains a highly bullish outlook for 2026, monitoring risks such as electrical grid constraints, tariff uncertainties, and geopolitical developments.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: The Driehaus Small/Mid Cap Growth Strategy capped 2025 with strong Q4 outperformance, positioning aggressively in secular industrials and biotech as small-cap earnings enter an exp...
Growth Outlook
Market outlook remains high conviction: The Driehaus Small/Mid Cap Growth Strategy capped 2025 with strong Q4 outperformance, positioning aggressively in secular industrials and biotech as small-cap earnings enter an exp...
Risk Appetite
Risk appetite posture is above average conviction: The Driehaus Small/Mid Cap Growth Strategy capped 2025 with strong Q4 outperformance, positioning aggressively in secular industrials and biotech as small-cap earnings enter an exp...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. The Driehaus Small/Mid Cap Growth Strategy capped 2025 with strong Q4 outperformance, positioning aggressively in secular industrials and biotech as small-cap earnings enter an exp...
Forward Guidance
Forward guidance signal: The Driehaus Small/Mid Cap Growth Strategy capped 2025 with strong Q4 outperformance, positioning aggressively in secular industrials and biotech as small-cap earnings enter an exp...
Language Signal
Tone analysis indicates above average conviction language: The Driehaus Small/Mid Cap Growth Strategy capped 2025 with strong Q4 outperformance, positioning aggressively in secular industrials and biotech as small-cap earnings enter an exp...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. The Driehaus Small/Mid Cap Growth Strategy capped 2025 with strong Q4 outperformance, positioning aggressively in secular industrials and biotech as small-cap earnings enter an exp...
Opportunity Density
Opportunity density index indicates high conviction actionable entry points. The Driehaus Small/Mid Cap Growth Strategy capped 2025 with strong Q4 outperformance, positioning aggressively in secular industrials and biotech as small-cap earnings enter an exp...
Time Horizon
Investment time horizon reflects a above average conviction orientation. The Driehaus Small/Mid Cap Growth Strategy capped 2025 with strong Q4 outperformance, positioning aggressively in secular industrials and biotech as small-cap earnings enter an exp...
